Literature DB >> 3605026

Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.

S Itoh, T Yougel, K Kawagoe.   

Abstract

Two groups, 16 nonalcoholic steatohepatitis patients (group I) and 22 alcoholic hepatitis patients (group II) classified according to the presence or absence of drinking and their histological characteristics, were compared on the basis of clinical, biochemical, and liver biopsy findings. The frequencies of female patients (p less than 0.01), obesity (p less than 0.001), and maturity-onset diabetes (p less than 0.005) were significantly greater in group I than in group II. The serum glutamic pyruvic transminase (p less than 0.05) and gamma-glutamyltranspeptidase (p less than 0.05) contents were significantly greater in group II than in group I. The cholinesterase content (p less than 0.05) was significantly less in group II. Significant differences were found in the grades of nuclear vacuolation (p less than 0.001, Fisher's exact probability test), periportal pericellular fibrosis, proliferation of bile ductules, and changes in the shape of the portal tracts (p less than 0.001, Wilcoxon's rank-sum test). Zonal necrosis in group I was seen in only severe steatohepatitis. These clinical and biochemical findings were found to be useful in differentiating nonalcoholic steatohepatitis from alcoholic hepatitis. Liver biopsy was of limited value at best in separating the two conditions.

Entities:  

Mesh:

Year:  1987        PMID: 3605026

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  24 in total

Review 1.  Mallory-Denk Bodies in chronic hepatitis.

Authors:  Metin Basaranoglu; Nesrin Turhan; Abdullah Sonsuz; Gökcen Basaranoglu
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

2.  Liver regeneration is not altered in patients with nonalcoholic steatohepatitis (NASH) when compared to chronic hepatitis C infection with similar grade of inflammation.

Authors:  Osamah Hussein; Sergio Szvalb; L M Van den Akker-Berman; Nimer Assy
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

3.  Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis.

Authors:  V Nehra; P Angulo; A L Buchman; K D Lindor
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

4.  Non-Alcoholic Fatty Liver Disease (NAFLD) in Obesity.

Authors:  Rushad Patell; Rupal Dosi; Harshal Joshi; Smit Sheth; Purav Shah; Sarfaraz Jasdanwala
Journal:  J Clin Diagn Res       Date:  2013-01-12

5.  Effects of emodin on treating murine nonalcoholic fatty liver induced by high caloric laboratory chaw.

Authors:  Hui Dong; Fu-Er Lu; Zhi-Qiang Gao; Li-Jun Xu; Kai-Fu Wang; Xin Zou
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

6.  Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis.

Authors:  A Nonomura; Y Mizukami; M Unoura; K Kobayashi; Y Takeda; R Takeda
Journal:  Gastroenterol Jpn       Date:  1992-08

7.  Metabolic conditions of fatty liver in non-diabetic obese women.

Authors:  B Kantarceken; A Cetinkaya; F Inanc Tolun; H Yerhan; C Citirik; M A Buyukbese
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

8.  Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful?

Authors:  Lili Kazemi-Shirazi; Moema Pinheiro Veloso; Florian Frommlet; Petra Steindl-Munda; Fritz Wrba; Sonja Zehetmayer; Claudia Marsik; Peter Ferenci
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

9.  Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis.

Authors:  Deepak Kumar Singh; Puja Sakhuja; Veena Malhotra; Ranjana Gondal; Shiv Kumar Sarin
Journal:  Dig Dis Sci       Date:  2007-11-21       Impact factor: 3.199

Review 10.  Pathogenesis and management issues for non-alcoholic fatty liver disease.

Authors:  Marko Duvnjak; Ivan Lerotić; Neven Barsić; Vedran Tomasić; Lucija Virović Jukić; Vedran Velagić
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.